Acrometa Group Limited Receives SGX-ST Approval for Listing of 16,666,667 New Shares

Key Highlights for Investors

• Approval for New Share Listing: Acrometa Group Limited has secured a Listing and Quotation Notice (LQN) from the Singapore Exchange Securities Trading Limited (SGX-ST) for the listing and quotation of 16,666,667 new ordinary shares in the company.
• Timeline for Placement: These new shares must be placed out within 7 market days from the date of the LQN, which was received on 29 April 2026.
• Share Subscription Details: The proposed subscription of new shares was first announced on 2 February 2026. The company will make further announcements upon the actual allotment and issuance of the Subscription Shares.
• Regulatory Disclaimer: The LQN from SGX-ST is not an endorsement or indication of the merits of the share subscription, the new shares, the company, or its subsidiaries and securities. The SGX-ST assumes no responsibility for the contents of the announcement.

Matters of Importance for Shareholders

• Potential Share Price Impact: The issuance of 16,666,667 new ordinary shares represents a significant increase in the company’s share capital, which could have a dilutive effect on existing shareholders’ percentage ownership. Investors should monitor for potential price movements as the market digests this development.
• Market Timing: The relatively short window (7 market days) for placing out the new shares suggests an imminent capital raising event, which may signal upcoming corporate initiatives, expansion, or investment plans.
• Future Updates: The company has committed to keeping investors updated with further announcements once the subscription shares have been allotted and issued.
• Sponsor’s Review: W Capital Markets Pte. Ltd. has reviewed the announcement as the company’s sponsor, though it is noted that the SGX-ST has not examined or approved the announcement.

Additional Details

• Contact Information: For further sponsor-related queries, investors may contact Mr. Brian Ching at W Capital Markets Pte. Ltd., 65 Chulia Street, #43-01, OCBC Centre, Singapore 049513, Telephone: (65) 6513 3537.
• Executive Sign-off: The announcement is issued by Mr. Toh Ker How, Executive Director of Acrometa Group Limited, dated 30 April 2026.

Conclusion

The approval from SGX-ST for the listing and quotation of 16,666,667 new shares is a significant development for Acrometa Group Limited. Shareholders should pay close attention to further announcements regarding the actual issuance and allotment of these shares, as well as any strategic moves the company may undertake with this new capital. The short placement timeline and potential dilution are key issues that may influence the company’s share price in the near term.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should seek professional advice and refer to official company announcements before making any investment decisions. The SGX-ST has not examined or approved the contents of this article.

View AcroMeta Historical chart here